AXP-1275

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAXP-1275
Drug Alias NameAXP-1275
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-C chemokine receptor type 3 antagonists
TargetsC-C chemokine receptor type 3
Therapy Area/IndicationsAllergic asthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAxikin Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAxikin Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAllergic asthma

Other Information

ATC CodeN/A
Related LinksN/A